The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Antibody Conjugation Service Market Research Report 2025
Synopsis
Antibody conjugation service refers to a process in which antibodies are chemically modified by attaching various tags or ligands to their specific binding sites, enabling them to bind to various targets such as cells, proteins, or other molecules. This process is typically performed by specialized laboratories or service providers using various conjugation techniques such as click conjugation, biotin-avidin binding, etc. The goal of this service is to improve the specificity and affinity of antibodies for their targets, as well as to enhance their functional capabilities.
The global Antibody Conjugation Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The industry trend for antibody conjugation service is towards increasing use in pharmaceutical and biotechnology research and development, as well as in clinical settings. With the growing demand for more advanced and specific antibody-based diagnostic and therapeutic tools, antibody conjugation services are becoming increasingly important. Additionally, the increasing use of antibody-based drugs in oncology and other diseases is driving the demand for such services, as they enable the development of more effective and targeted treatment strategies. Furthermore, the trend towards more sustainable and environmentally friendly research and production methods is also contributing to the growth of antibody conjugation services, as they reduce the use of toxic chemicals and minimize the environmental impact of antibody production.
This report aims to provide a comprehensive presentation of the global market for Antibody Conjugation Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Conjugation Service.
Report Scope
The Antibody Conjugation Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antibody Conjugation Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody Conjugation Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ProSci, Inc
Thermo Fisher Scientific
Abcam
Cell Signaling Technology
Bio X Cell
SouthernBiotech
Novus Biologicals
GenScript
Leinco Technologies
Standard BioTools
AlphaThera
Creative Biolabs
Antibodies
Boster Biological Technology
Cygnus Technologies
Cayman Chemical
GeneTex
ProteoGenix
Levena Biopharma
Merck
Lonza
Charles River
Segment by Type
Chemical Compound
Fluorescent Group
Isotope
Protein
Segment by Application
Biotechnology
Medical
University
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibody Conjugation Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Antibody conjugation service refers to a process in which antibodies are chemically modified by attaching various tags or ligands to their specific binding sites, enabling them to bind to various targets such as cells, proteins, or other molecules. This process is typically performed by specialized laboratories or service providers using various conjugation techniques such as click conjugation, biotin-avidin binding, etc. The goal of this service is to improve the specificity and affinity of antibodies for their targets, as well as to enhance their functional capabilities.
The global Antibody Conjugation Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The industry trend for antibody conjugation service is towards increasing use in pharmaceutical and biotechnology research and development, as well as in clinical settings. With the growing demand for more advanced and specific antibody-based diagnostic and therapeutic tools, antibody conjugation services are becoming increasingly important. Additionally, the increasing use of antibody-based drugs in oncology and other diseases is driving the demand for such services, as they enable the development of more effective and targeted treatment strategies. Furthermore, the trend towards more sustainable and environmentally friendly research and production methods is also contributing to the growth of antibody conjugation services, as they reduce the use of toxic chemicals and minimize the environmental impact of antibody production.
This report aims to provide a comprehensive presentation of the global market for Antibody Conjugation Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibody Conjugation Service.
Report Scope
The Antibody Conjugation Service market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antibody Conjugation Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Antibody Conjugation Service companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
ProSci, Inc
Thermo Fisher Scientific
Abcam
Cell Signaling Technology
Bio X Cell
SouthernBiotech
Novus Biologicals
GenScript
Leinco Technologies
Standard BioTools
AlphaThera
Creative Biolabs
Antibodies
Boster Biological Technology
Cygnus Technologies
Cayman Chemical
GeneTex
ProteoGenix
Levena Biopharma
Merck
Lonza
Charles River
Segment by Type
Chemical Compound
Fluorescent Group
Isotope
Protein
Segment by Application
Biotechnology
Medical
University
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Antibody Conjugation Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antibody Conjugation Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Chemical Compound
1.2.3 Fluorescent Group
1.2.4 Isotope
1.2.5 Protein
1.3 Market by Application
1.3.1 Global Antibody Conjugation Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 University
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Antibody Conjugation Service Market Perspective (2019-2030)
2.2 Antibody Conjugation Service Growth Trends by Region
2.2.1 Global Antibody Conjugation Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Antibody Conjugation Service Historic Market Size by Region (2019-2024)
2.2.3 Antibody Conjugation Service Forecasted Market Size by Region (2025-2030)
2.3 Antibody Conjugation Service Market Dynamics
2.3.1 Antibody Conjugation Service Industry Trends
2.3.2 Antibody Conjugation Service Market Drivers
2.3.3 Antibody Conjugation Service Market Challenges
2.3.4 Antibody Conjugation Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Antibody Conjugation Service Players by Revenue
3.1.1 Global Top Antibody Conjugation Service Players by Revenue (2019-2024)
3.1.2 Global Antibody Conjugation Service Revenue Market Share by Players (2019-2024)
3.2 Global Antibody Conjugation Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Antibody Conjugation Service Revenue
3.4 Global Antibody Conjugation Service Market Concentration Ratio
3.4.1 Global Antibody Conjugation Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antibody Conjugation Service Revenue in 2023
3.5 Antibody Conjugation Service Key Players Head office and Area Served
3.6 Key Players Antibody Conjugation Service Product Solution and Service
3.7 Date of Enter into Antibody Conjugation Service Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Antibody Conjugation Service Breakdown Data by Type
4.1 Global Antibody Conjugation Service Historic Market Size by Type (2019-2024)
4.2 Global Antibody Conjugation Service Forecasted Market Size by Type (2025-2030)
5 Antibody Conjugation Service Breakdown Data by Application
5.1 Global Antibody Conjugation Service Historic Market Size by Application (2019-2024)
5.2 Global Antibody Conjugation Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Antibody Conjugation Service Market Size (2019-2030)
6.2 North America Antibody Conjugation Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Antibody Conjugation Service Market Size by Country (2019-2024)
6.4 North America Antibody Conjugation Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Antibody Conjugation Service Market Size (2019-2030)
7.2 Europe Antibody Conjugation Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Antibody Conjugation Service Market Size by Country (2019-2024)
7.4 Europe Antibody Conjugation Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Antibody Conjugation Service Market Size (2019-2030)
8.2 Asia-Pacific Antibody Conjugation Service Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Antibody Conjugation Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Antibody Conjugation Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Antibody Conjugation Service Market Size (2019-2030)
9.2 Latin America Antibody Conjugation Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Antibody Conjugation Service Market Size by Country (2019-2024)
9.4 Latin America Antibody Conjugation Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Antibody Conjugation Service Market Size (2019-2030)
10.2 Middle East & Africa Antibody Conjugation Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Antibody Conjugation Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Antibody Conjugation Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ProSci, Inc
11.1.1 ProSci, Inc Company Detail
11.1.2 ProSci, Inc Business Overview
11.1.3 ProSci, Inc Antibody Conjugation Service Introduction
11.1.4 ProSci, Inc Revenue in Antibody Conjugation Service Business (2019-2024)
11.1.5 ProSci, Inc Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Detail
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Antibody Conjugation Service Introduction
11.2.4 Thermo Fisher Scientific Revenue in Antibody Conjugation Service Business (2019-2024)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Abcam
11.3.1 Abcam Company Detail
11.3.2 Abcam Business Overview
11.3.3 Abcam Antibody Conjugation Service Introduction
11.3.4 Abcam Revenue in Antibody Conjugation Service Business (2019-2024)
11.3.5 Abcam Recent Development
11.4 Cell Signaling Technology
11.4.1 Cell Signaling Technology Company Detail
11.4.2 Cell Signaling Technology Business Overview
11.4.3 Cell Signaling Technology Antibody Conjugation Service Introduction
11.4.4 Cell Signaling Technology Revenue in Antibody Conjugation Service Business (2019-2024)
11.4.5 Cell Signaling Technology Recent Development
11.5 Bio X Cell
11.5.1 Bio X Cell Company Detail
11.5.2 Bio X Cell Business Overview
11.5.3 Bio X Cell Antibody Conjugation Service Introduction
11.5.4 Bio X Cell Revenue in Antibody Conjugation Service Business (2019-2024)
11.5.5 Bio X Cell Recent Development
11.6 SouthernBiotech
11.6.1 SouthernBiotech Company Detail
11.6.2 SouthernBiotech Business Overview
11.6.3 SouthernBiotech Antibody Conjugation Service Introduction
11.6.4 SouthernBiotech Revenue in Antibody Conjugation Service Business (2019-2024)
11.6.5 SouthernBiotech Recent Development
11.7 Novus Biologicals
11.7.1 Novus Biologicals Company Detail
11.7.2 Novus Biologicals Business Overview
11.7.3 Novus Biologicals Antibody Conjugation Service Introduction
11.7.4 Novus Biologicals Revenue in Antibody Conjugation Service Business (2019-2024)
11.7.5 Novus Biologicals Recent Development
11.8 GenScript
11.8.1 GenScript Company Detail
11.8.2 GenScript Business Overview
11.8.3 GenScript Antibody Conjugation Service Introduction
11.8.4 GenScript Revenue in Antibody Conjugation Service Business (2019-2024)
11.8.5 GenScript Recent Development
11.9 Leinco Technologies
11.9.1 Leinco Technologies Company Detail
11.9.2 Leinco Technologies Business Overview
11.9.3 Leinco Technologies Antibody Conjugation Service Introduction
11.9.4 Leinco Technologies Revenue in Antibody Conjugation Service Business (2019-2024)
11.9.5 Leinco Technologies Recent Development
11.10 Standard BioTools
11.10.1 Standard BioTools Company Detail
11.10.2 Standard BioTools Business Overview
11.10.3 Standard BioTools Antibody Conjugation Service Introduction
11.10.4 Standard BioTools Revenue in Antibody Conjugation Service Business (2019-2024)
11.10.5 Standard BioTools Recent Development
11.11 AlphaThera
11.11.1 AlphaThera Company Detail
11.11.2 AlphaThera Business Overview
11.11.3 AlphaThera Antibody Conjugation Service Introduction
11.11.4 AlphaThera Revenue in Antibody Conjugation Service Business (2019-2024)
11.11.5 AlphaThera Recent Development
11.12 Creative Biolabs
11.12.1 Creative Biolabs Company Detail
11.12.2 Creative Biolabs Business Overview
11.12.3 Creative Biolabs Antibody Conjugation Service Introduction
11.12.4 Creative Biolabs Revenue in Antibody Conjugation Service Business (2019-2024)
11.12.5 Creative Biolabs Recent Development
11.13 Antibodies
11.13.1 Antibodies Company Detail
11.13.2 Antibodies Business Overview
11.13.3 Antibodies Antibody Conjugation Service Introduction
11.13.4 Antibodies Revenue in Antibody Conjugation Service Business (2019-2024)
11.13.5 Antibodies Recent Development
11.14 Boster Biological Technology
11.14.1 Boster Biological Technology Company Detail
11.14.2 Boster Biological Technology Business Overview
11.14.3 Boster Biological Technology Antibody Conjugation Service Introduction
11.14.4 Boster Biological Technology Revenue in Antibody Conjugation Service Business (2019-2024)
11.14.5 Boster Biological Technology Recent Development
11.15 Cygnus Technologies
11.15.1 Cygnus Technologies Company Detail
11.15.2 Cygnus Technologies Business Overview
11.15.3 Cygnus Technologies Antibody Conjugation Service Introduction
11.15.4 Cygnus Technologies Revenue in Antibody Conjugation Service Business (2019-2024)
11.15.5 Cygnus Technologies Recent Development
11.16 Cayman Chemical
11.16.1 Cayman Chemical Company Detail
11.16.2 Cayman Chemical Business Overview
11.16.3 Cayman Chemical Antibody Conjugation Service Introduction
11.16.4 Cayman Chemical Revenue in Antibody Conjugation Service Business (2019-2024)
11.16.5 Cayman Chemical Recent Development
11.17 GeneTex
11.17.1 GeneTex Company Detail
11.17.2 GeneTex Business Overview
11.17.3 GeneTex Antibody Conjugation Service Introduction
11.17.4 GeneTex Revenue in Antibody Conjugation Service Business (2019-2024)
11.17.5 GeneTex Recent Development
11.18 ProteoGenix
11.18.1 ProteoGenix Company Detail
11.18.2 ProteoGenix Business Overview
11.18.3 ProteoGenix Antibody Conjugation Service Introduction
11.18.4 ProteoGenix Revenue in Antibody Conjugation Service Business (2019-2024)
11.18.5 ProteoGenix Recent Development
11.19 Levena Biopharma
11.19.1 Levena Biopharma Company Detail
11.19.2 Levena Biopharma Business Overview
11.19.3 Levena Biopharma Antibody Conjugation Service Introduction
11.19.4 Levena Biopharma Revenue in Antibody Conjugation Service Business (2019-2024)
11.19.5 Levena Biopharma Recent Development
11.20 Merck
11.20.1 Merck Company Detail
11.20.2 Merck Business Overview
11.20.3 Merck Antibody Conjugation Service Introduction
11.20.4 Merck Revenue in Antibody Conjugation Service Business (2019-2024)
11.20.5 Merck Recent Development
11.21 Lonza
11.21.1 Lonza Company Detail
11.21.2 Lonza Business Overview
11.21.3 Lonza Antibody Conjugation Service Introduction
11.21.4 Lonza Revenue in Antibody Conjugation Service Business (2019-2024)
11.21.5 Lonza Recent Development
11.22 Charles River
11.22.1 Charles River Company Detail
11.22.2 Charles River Business Overview
11.22.3 Charles River Antibody Conjugation Service Introduction
11.22.4 Charles River Revenue in Antibody Conjugation Service Business (2019-2024)
11.22.5 Charles River Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
